# Idexx Laboratories Inc: Form 8-K, filed Aug 1, 2023

- Company: [Idexx Laboratories Inc](/companies/idxx.md) (CIK 874716)
- Form: 8-K
- Filed: 2023-08-01
- Accepted by EDGAR: Aug 1, 2023, 06:30 ET
- Period: 2023-08-01
- Accession: 0001157523-23-001198
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/874716/000115752323001198/a53494439.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/874716/000115752323001198/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/874716/000115752323001198/a53494439.htm

Filed Aug 1, 2023.
Source: SEC EDGAR, the filing index for accession 0001157523-23-001198. Last ingested by Listed: Nov 13, 2026, 16:34 ET. No prices; not investment advice.
